RESEARCH TRIANGLE PARK, N.C. – June 6, 2007 – Quintiles Transnational Corp. today announced that it plans to build a new office near Edinburgh that will be the Scotland home for its Product Development business, including Quintiles Laboratories, and its NovaQuest group. The company also will add 150 jobs in Scotland over the next four years.

The new 112,000-square-foot structure – which Quintiles could expand to 132,000 square feet – will be built in Livingston, West Lothian, near Quintiles’ present 36,500-square-foot laboratory. The new building will provide about 80,000 square feet of space for the laboratory business. Quintiles’ Product Development and NovaQuest personnel occupy about 25,000 square feet in a Bathgate office, and these units also will move into the new building. Quintiles has 390 employees in the two locations.
“Our lab business is expanding – globally and in Europe – because of our proximity to clinical trial sites and our tight quality control,” said Thomas Wollman, Senior Vice President, Global Central Laboratories. “This new facility will enhance our level of customer service in the UK and Europe, just as our new central lab in Mumbai has improved service in India. We will continue to look for opportunities to strengthen our global central lab network.”

The new structure will be developed and built by the Keith Corporation of Charlotte, N.C., on the Alba Campus business park in Livingston, about 15 miles from Edinburgh city center. Quintiles will sign a 15-year lease for the facility. Quintiles is receiving a $2.4 million Regional Selective Assistance Grant from the Scottish Executive to help offset some of the company’s $13 million investment in the new building. Under terms of the grant agreement, Quintiles has agreed to add 150 jobs over the next four years.

“We want to thank West Lothian Council, the Scottish Executive and Scottish Enterprise for their support in our project,” said Graham Murray, General Manager, Quintiles Laboratories Europe. “Their assistance, particularly the Regional Selective Assistance grant, was instrumental in our decision to expand in Livingston.”

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With about 18,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company’s Web site at www.quintiles.com.